Bellevue Group reported a 5% stake in Jade Biosciences JBIO · 3,057,996 sh · amendment · passive holder

Trade details

Type: 5% stake report
Report: 13G passive · amendment
Stake: 5%
Last report: 6.8% · filed 26/02/17
Shares held: 3,057,996 sh
Class: Common Stock
Stock: Jade Biosciences JBIO
Holder: Bellevue Group
Event date: 26/06/30
Filed: 26/08/14

5% stake · −1.8pp from the last report

Stake: 5%
Last report: 6.8%
Since last report: −1.8pp

Jade Biosciences trades, last 26 weeks

What else happened in Jade Biosciences around then

Filed or reported within 30 days of the trade day · 05/31~07/30

Bellevue Group's other 5% stake reports

Bellevue Group
5% stakeViridian Therapeutics, Inc.\DE
5% stake
Viridian Therapeutics, Inc.\DE
VRDN
6.6% stake
6,726,144 sh
6.6% stake
Filed 05/15
Bellevue Group
5% stakeCelldex Therapeutics
5% stake
Celldex Therapeutics
CLDX
1.5% stake
1,200,000 sh
1.5% stake
Filed 05/15
Bellevue Group
5% stakeJade Biosciences
5% stake
Jade Biosciences
JBIO
6.8% stake
3,341,103 sh
6.8% stake
Filed 02/17
Bellevue Group
5% stakeMacrogenics
5% stake
Macrogenics
MGNX
0% stake
0 sh
0% stake
Filed 01/06
Bellevue Group
5% stakeAgios Pharmaceuticals
5% stake
Agios Pharmaceuticals
AGIO
0% stake
0 sh
0% stake
Filed 25/12/05